PRC-Saltillo and Team Gleason Partner to Help People with ALS Stay Connected
WOOSTER, Ohio and NEW ORLEANS, Nov. 6, 2026 /PRNewswire/ -- For people living with ALS, maintaining communication can mean preserving...
Day: November 6, 2026
Inimmune Presents Late-Breaking Phase 1 INI-4001 Results Demonstrating On-Target Immune Activation in Advanced Solid Tumors at SITC 2026
Study demonstrated no dose-limiting toxicities and dose-responsive cytokine production consistent with TLR7/8 engagementResults support continued clinical development of INI-4001 as...
AeroSafe Global Named to Greater Rochester Chamber Top 100 List
ROCHESTER, N.Y., Nov. 6, 2026 /PRNewswire/ -- AeroSafe Global, a pioneer in Cold-Chain-as-a-Service (CCaaS) for the pharmaceutical industry, is proud...
FinThrive Appoints Sam Meckey as Chief Executive Officer
Experienced healthcare technology and operations executive to lead FinThrive's next chapter of innovation, operational excellence and growthCEO Hemant Goel to...
Stanford Radiologist and AI Leader Curtis Langlotz, MD, PhD, Joins Raidium Strategic Advisory Board
Langlotz will advise on how AI-assisted radiology reporting is validated and built around radiologists; Raidium to host November 10 webinar...
Findhelp Selected by Hawai’i Department of Corrections and Rehabilitation to Modernize Community Referrals for People in Its Care
Statewide digital infrastructure will connect correctional facilities, field staff, and community partners across all four counties to streamline care delivery,...
Zimmer Biomet Introduces Surgeon-Guided Autonomy, a New Category in Intelligent Surgery
New Category Will Introduce a Closed-Loop Framework: Predict. Perform. Recover. Keeping the Surgeon's Expertise and Control at the Center of...
CREATE Medicines to Host Investor and Partnering Meetings at the 2026 Jefferies Global Healthcare Conference in London
Discussions will highlight progress from CREATE's four clinical-stage in vivo CAR programs across autoimmune disease and oncologyCAMBRIDGE, Mass., Nov. 6,...
ACOFP Names Timothy W. McNichol, Esq., as Executive Director
Experienced osteopathic association executive to succeed Bob Moore in January 2027 CHICAGO, IL / ACCESS Newswire / November 6, 2026...
Phio Pharmaceuticals Announces Invitation for Oral Presentation at 41st Annual SITC Meeting (Society for Immunotherapy of Cancer)
INTASYL siRNA - Redefining the Treatment Paradigm for Cutaneous Squamous Cell CarcinomaKing of Prussia, Pennsylvania--(Newsfile Corp. - November 6, 2026)...
BetterLife Pharma Announces Settlement of Claim with Dr. Steven Sangha
- Adoption of Advance Notice Policy -- Appointment of LifeSci Advisors - Vancouver, British Columbia--(Newsfile Corp. - November 6, 2026)...
Kos Biotechnology Partners Announces Investment in Fathom Therapeutics to Advance Novel, AI-Driven Drug Discovery Platform
Kos joins Sutter Hill Ventures and other leading investors in backing Fathom Therapeutics's pioneering physics- and AI-powered drug discovery platformNEW...
Moderna Reports Third Quarter 2026 Financial Results and Provides Business Updates
Reports third quarter revenue of $1.3 billion, GAAP net income of $0.2 billion and GAAP diluted EPS of $0.38Increases 2026...
Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Advances PBH Development Program Following August 2026 Initial Public OfferingStrengthens Balance Sheet with $82.1 Million in Total Cash, Cash Equivalents,...
BioScience Health Innovations, Inc. Announces Its Subsidiary Vitalcore Research has Executed Master Distribution Agreement with Rule Imports
Agreement adds $250,000 in research funding and a master distributor relationship to support product development and commercialization across Vitalcore, Best365Labs...
Nxera Pharma Announces Vamorolone Selected for South Korea’s Accelerated Reimbursement Pilot Program for Rare Disease Treatments
Vamorolone is one of five treatments selected for the rare disease reimbursement pilot program.The program aims to shorten the National...
Ultragenyx Announces the Marketing Authorisation Application (MAA) for its Investigational Gene Therapy for MPS IIIA (Sanfilippo syndrome Type A) is Under Review with the UK Medicines and Healthcare Products Regulatory Agency (MHRA)
BASEL, Switzerland, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Ultragenyx (NASDAQ:RARE), a biopharmaceutical company focused on the development and commercialisation of...
Avance Clinical Brings 30 Years of Early-Phase and Therapeutic Leadership to European Biotechs at BIO-Europe 2026
Australian fast-start pathway, four Centers of Excellence and a GlobalReady model that takes programs from first-in-human to global Phase II...
MHRA approves Pharming’s Joenja® (leniolisib) as first treatment specifically for children with APDS in the U.K.
Approval extends existing U.K. indication for Joenja to eligible children aged 4 to 11 who weigh at least 27 kgJoenja...
Orchestra BioMed Announces Pricing of Public Offering
NEW HOPE, Pa., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”),...